The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis. Duddy M, Palace J Pract Neurol. 2015 Oct 1. PMID: 26430247. Abstract CommentRecommendBookmarkWatch